Read More Pharma Industry News Roche’s Perjeta shows significant promise in phase 3 breast cancer trial Roche has announced promising results from the APHINITY trial, a crucial Phase 3 study evaluating Perjeta (pertuzumab) in… bypharmanewsdailyMarch 2, 2017
